{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:53:07Z","timestamp":1790344387094,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2003,3]]},"DOI":"10.1053\/ajkd.2003.50140","type":"journal-article","created":{"date-parts":[[2003,2,28]],"date-time":"2003-02-28T17:48:30Z","timestamp":1046454510000},"page":"565-570","source":"Crossref","is-referenced-by-count":246,"title":["A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease"],"prefix":"10.1053","volume":"41","author":[{"given":"Stefano","family":"Bianchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Bigazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Caiazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito M.","family":"Campese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/ajkd.2003.50140_bib1","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/ndt\/12.9.1908","article-title":"Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency","volume":"12","author":"Samuelsson","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2003.50140_bib2","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/00041552-199305000-00005","article-title":"Lipid abnormalities and changes in plasma proteins in glomerular diseases and chronic renal failure","volume":"2","author":"Guijarro","year":"1993","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1053\/ajkd.2003.50140_bib3","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1093\/oxfordjournals.ndt.a027142","article-title":"Plasma levels of Lipoprotein (a) do not predict progression of human chronic renal failure","volume":"11","author":"Samuelsson","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2003.50140_bib4","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1056\/NEJM199008303230905","article-title":"Abnormalities of lipoprotein metabolism in patients with nephrotic syndrome","volume":"323","author":"Joven","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1053\/ajkd.2003.50140_bib5","first-page":"S134","article-title":"Is aggressive management of hyperlipidemia in nephrotic syndrome mandatory?","volume":"42","author":"Keane","year":"1992","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2003.50140_bib6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0021-9150(85)90181-9","article-title":"Lipoprotein distribution and composition in human nephrotic syndrome","volume":"54","author":"Muls","year":"1985","journal-title":"Atherosclerosis"},{"issue":"Suppl 31","key":"10.1053\/ajkd.2003.50140_bib7","first-page":"S8","article-title":"Hyperlypidemia of the nephrotic syndrome","volume":"39","author":"Kaysen","year":"1991","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2003.50140_bib8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0272-6386(12)80994-2","article-title":"Lipid abnormalities in the nephrotic syndrome: Causes, consequences and treatment","volume":"23","author":"Wheeler","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2003.50140_bib9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0272-6386(12)70179-8","article-title":"The nephrotic syndrome, lipids and risk factors for cardiovascular diseases","volume":"22","author":"Radhakrishnan","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2003.50140_bib10","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/ki.1993.292","article-title":"The increased risk of coronary heart diseases associated with nephrotic syndrome","volume":"44","author":"Ordonez","year":"1993","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2003.50140_bib11","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/archinte.158.9.998","article-title":"Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure and hyperglycemia","volume":"158","author":"Ravid","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1053\/ajkd.2003.50140_bib12","first-page":"S125","article-title":"Hypercholesterolemia a determinant of renal function loss and deaths in IDDM patients with nephropathy","volume":"45","author":"Krolewski","year":"1994","journal-title":"Kidney Int Suppl"},{"key":"10.1053\/ajkd.2003.50140_bib13","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000187210","article-title":"Apolipoprotein-B-containing lipoproteins and the progression of renal insufficiency","volume":"63","author":"Samuelsson","year":"1993","journal-title":"Nephron"},{"key":"10.1053\/ajkd.2003.50140_bib14","first-page":"51N","article-title":"Serum lipids in patients with chronic renal failure on long term protein restricted diets","volume":"87","author":"Maschio","year":"1989","journal-title":"Am J Med"},{"key":"10.1053\/ajkd.2003.50140_bib15","first-page":"104","article-title":"Serum lipid concentrations correlate with the progression of chronic renal failure","volume":"12","author":"Yang","year":"1999","journal-title":"Clin Lab Sci"},{"key":"10.1053\/ajkd.2003.50140_bib16","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/ki.1997.260","article-title":"Predictors of the progression of renal disease in the modification of diet in renal disease study","volume":"51","author":"Hunsicker","year":"1997","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2003.50140_bib17","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1046\/j.1523-1755.1999.07101.x","article-title":"Recent advances in statins and the kidney","volume":"71","author":"Oda","year":"1999","journal-title":"Kidney Int Suppl"},{"key":"10.1053\/ajkd.2003.50140_bib18","first-page":"S36","article-title":"Lipids in progression of renal diseases","volume":"62","author":"Oda","year":"1997","journal-title":"Kidney Int Suppl"},{"key":"10.1053\/ajkd.2003.50140_bib19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/oxfordjournals.ndt.a092102","article-title":"Lovastatin in glomerulonephritic patients with hyperlipidemia and heavy proteinuria","volume":"7","author":"Chan","year":"1992","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2003.50140_bib20","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1159\/000189106","article-title":"Effects of hypercholesterolemia on renal hemodynamics: Study in patients with nephrotic syndrome","volume":"73","author":"Fuiano","year":"1996","journal-title":"Nephron"},{"key":"10.1053\/ajkd.2003.50140_bib21","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/ki.1993.129","article-title":"Apolipoproteins and lipoprotein-receptors in glomeruli in human kidney diseases","volume":"43","author":"Takemura","year":"1993","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2003.50140_bib22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1172\/JCI116204","article-title":"Lovastatin inhibits proliferation of rat mesangial cells","volume":"91","author":"O'Donnell","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1053\/ajkd.2003.50140_bib23","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/ki.1992.177","article-title":"Interactions of LDL and modified LDL with mesangial cells and matrix","volume":"41","author":"Gupta","year":"1992","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2003.50140_bib24","first-page":"33","article-title":"Interstitial foam cells and oxidized lipoprotein in human glomerular disease","volume":"12","author":"Magil","year":"1999","journal-title":"Mod Pathol"},{"key":"10.1053\/ajkd.2003.50140_bib25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1681\/ASN.V42187","article-title":"Oxidative modification of low density lipoproteins by mesangial cells","volume":"4","author":"Keane","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2003.50140_bib26","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/ki.1991.108","article-title":"Preferential binding of oxidized LDL to rat glomeruli in vivo and cultured mesangial cells in vitro","volume":"39","author":"Coritsidis","year":"1991","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2003.50140_bib27","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1073\/pnas.84.9.2995","article-title":"Oxidatively modified low density lipoproteins: A potential role in recruitment and retention of monocyte\/macrophages during atherogenesis","volume":"84","author":"Quenn","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/ajkd.2003.50140_bib28","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/ki.1993.35","article-title":"LDL stimulates mesangial fibronectin production and chemoattractant expression","volume":"43","author":"Rovin","year":"1993","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2003.50140_bib29","first-page":"635A","article-title":"Oxidized low density lipoprotein increases mesangial cell expression of type IV collagen [alfa 1 (IV)] m-RNA","volume":"3","author":"Keane","year":"1992","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2003.50140_bib30","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/ndt\/14.11.2585","article-title":"Angiotensin II and oxidized LDL. An unholy alliance creating oxidative stress","volume":"14","author":"Galle","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2003.50140_bib31","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ki.1997.423","article-title":"Lovastatin-induced inhibition of renal epithelial tubular cell proliferation involves a p21ras activated, AP-1-dependent pathway","volume":"52","author":"Vrtovsnik","year":"1997","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2003.50140_bib32","doi-asserted-by":"crossref","first-page":"114A","DOI":"10.1016\/S0002-9149(05)80031-1","article-title":"Effects of fluvastatin on growth of porcine and human vascular smooth muscle cells in vitro","volume":"76","author":"Rogler","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1053\/ajkd.2003.50140_bib33","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/oxfordjournals.ndt.a027522","article-title":"Lovastatin inhibits lipopolysaccharide-induced NF-[kappa]B activation in human mesangial cells","volume":"11","author":"Guijarro","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2003.50140_bib34","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/ki.1995.304","article-title":"Human mesangial cell production of monocyte chemoattractant protein-1: Modulation by lovastatin","volume":"48","author":"Kim","year":"1995","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2003.50140_bib35","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/ajkd.1998.v31.pm9428473","article-title":"Lovastatin reduces glomerular macrophage influx and expression of monocyte chemoattractant protein-I mRNA in nephrotic rats","volume":"31","author":"Park","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2003.50140_bib36","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.CIR.97.12.1129","article-title":"Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors","volume":"97","author":"Laufs","year":"1998","journal-title":"Circulation"},{"key":"10.1053\/ajkd.2003.50140_bib37","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1172\/JCI1500","article-title":"Effects of the 3-hydroxy-3-methyl glutaryl-CoA reductase inhibitors atorvastatin and simvastatin, on the expression of endothelin 1 and endothelial nitric oxide synthase in vascular endothelial cells","volume":"101","author":"Hernandez Perera","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1053\/ajkd.2003.50140_bib38","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1161\/01.CIR.95.5.1126","article-title":"Simvastatin, an HMG-coenzyme reductase inhibitor, improves endothelial function within 1 month","volume":"95","author":"O'Driscoll","year":"1997","journal-title":"Circulation"},{"key":"10.1053\/ajkd.2003.50140_bib39","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1161\/01.RES.83.5.490","article-title":"3-Hydroxy-3-methylglutaryl coenzyme A reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture","volume":"83","author":"Guijarro","year":"1998","journal-title":"Circ Res"},{"key":"10.1053\/ajkd.2003.50140_bib40","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1681\/ASN.V5112","article-title":"Apoptosis and the kidney","volume":"5","author":"Savill","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2003.50140_bib41","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/01.HYP.0000022805.11288.7F","article-title":"Effect of pravastatin on proteinuria in patients with well-controlled hypertension","volume":"40","author":"Lee","year":"2002","journal-title":"Hypertension"},{"key":"10.1053\/ajkd.2003.50140_bib42","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1046\/j.1523-1755.2001.00487.x","article-title":"Effects of lipid reduction on the progression of renal disease: A meta-analysis","volume":"59","author":"Fried","year":"2001","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2003.50140_bib43","first-page":"219","article-title":"A prospective clinical trial comparing the treatment of idiopathic membranous nephropathy and nephrotic syndrome with simvastatin and diet, versus diet alone","volume":"46","author":"Rayner","year":"1996","journal-title":"Clin Nephrol"},{"key":"10.1053\/ajkd.2003.50140_bib44","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1067\/mcp.2000.105330","article-title":"Effects of fluvastatin on proteinuria in patients with immunoglobulin A nephropathy","volume":"67","author":"Buemi","year":"2000","journal-title":"Clin Pharm Ther"},{"key":"10.1053\/ajkd.2003.50140_bib45","first-page":"523","article-title":"Effect of pravastatin on hypercholesterolemia associated with proteinuria","volume":"11","author":"Aranda Arcas","year":"1994","journal-title":"Ann Med Intern"},{"key":"10.1053\/ajkd.2003.50140_bib46","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0022-3476(97)70213-0","article-title":"Management of hyperlipidemia in children with refractory nephrotic syndrome: The effect of statin therapy","volume":"130","author":"Sanjad","year":"1997","journal-title":"J Pediatr"},{"key":"10.1053\/ajkd.2003.50140_bib47","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1067\/mcp.2000.109787","article-title":"Simvastatin, capillary permeability, and acetylcholine-mediated vasomotion in atherosclerotic, hypercholesterolemic men","volume":"68","author":"Dell'Omo","year":"2000","journal-title":"Clin Pharmacol Ther"}],"updated-by":[{"DOI":"10.1053\/j.ajkd.2003.10.007","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000}}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638602692479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638602692479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T23:02:45Z","timestamp":1622847765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638602692479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["S0272638602692479"],"URL":"https:\/\/doi.org\/10.1053\/ajkd.2003.50140","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2003,3]]}}}